Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filings

Filing date Description Form Filing Group View

Quarterly report which provides a continuing view of a company's financial position

 10-Q
Quarterly Filings
0001564590-18-021717.pdf
0001564590-18-021717.rtf
0001564590-18-021717.xls
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Initial filing by director officer or owner of more than ten percent.

 3
3,4,5
0001209191-18-039088.pdf
0001209191-18-039088.rtf
View HTML

Initial filing by director officer or owner of more than ten percent.

 3
3,4,5
0001209191-18-039087.pdf
0001209191-18-039087.rtf
View HTML

Initial filing by director officer or owner of more than ten percent.

 3
3,4,5
0001209191-18-039091.pdf
0001209191-18-039091.rtf
View HTML

Initial filing by director officer or owner of more than ten percent.

 3
3,4,5
0001209191-18-039089.pdf
0001209191-18-039089.rtf
View HTML

Initial filing by director officer or owner of more than ten percent.

 3
3,4,5
0001209191-18-039090.pdf
0001209191-18-039090.rtf
View HTML

Initial filing by director officer or owner of more than ten percent.

 3
3,4,5
0001209191-18-039092.pdf
0001209191-18-039092.rtf
View HTML

Initial filing by director officer or owner of more than ten percent.

 3
3,4,5
0001209191-18-039098.pdf
0001209191-18-039098.rtf
View HTML

Initial filing by director officer or owner of more than ten percent.

 3
3,4,5
0001209191-18-039099.pdf
0001209191-18-039099.rtf
View HTML

Initial filing by director officer or owner of more than ten percent.

 3
3,4,5
0001209191-18-039097.pdf
0001209191-18-039097.rtf
View HTML
Displaying 1 - 10 of 32 results

Copyright Morningstar